About KindredBio
KindredBio is a Healthcare company based in Burlingame (United States) founded in 2012, and was acquired by Elanco in June 2021. Veterinary antibodies for cats, dogs, and horses are developed. KindredBio has raised $6.9 million across 3 funding rounds from investors including Elanco and SLR Investment Corp. The company has 64 employees. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Diversified. Its legal entity is KINDRED BIOSCIENCES, INC.
Company details
Kindred Biosciences was founded in 2012 and is headquartered in Burlingame, United States. Operations are centered on veterinary biotechnology, with a focus on antibody-based therapies for animal diseases. Treatments targeting conditions in cats, dogs, and horses have been developed by the company. Activities encompass research and development within the animal health sector, supporting therapeutic advancements for companion and equine species.
- Headquarters Burlingame, United States
- Employees 64
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kindredbio.com
- Social LinkedIn X Facebook
- Acquired by Elanco (Jun 2021)
- Legal Name Kindred Biosciences, Inc.
- Annual Revenue$42.16 M (USD)891as on Dec 31, 2020
- Net Profit-$21.8 M (USD)64as on Dec 31, 2020
- EBITDA-$19.97 M (USD)68as on Dec 31, 2020
- Total Equity Funding$6.9M (USD)
in 3 rounds
- Latest Funding Round$50M (USD), Debt – Conventional
Oct 2019
- InvestorsElanco
& 1 more
- Employee Count64
- Acquired byElanco
(Jun 2021)
Funding Insights of KindredBio
KindredBio has successfully raised a total of $6.9M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.9M
- Total Rounds 3
- Last Round Debt – Conventional — $50M
- First Round $1M
(Nov 2012)
- Investors Count 1
All 3 funding rounds of KindredBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $50M | Debt – Conventional | – | – | |
| Sep 2013 | $5.9M | Series A | – | – | – |
| Nov 2012 | $1M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in KindredBio
KindredBio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Elanco and SLR Investment Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Debt and equity investments are offered by the firm. | 2006 | solarcapltd.com | New York, United States | |
Veterinary food and medicines products are provided for animal health. | 1954 | elanco.com | Greenfield, United States |
Investor details for KindredBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of KindredBio
660 people are tracked at KindredBio (245 in leadership, 12 in board & advisors, 403 in team); the tracked headcount is 64.
| Name | Role | Group |
|---|---|---|
Lisa McMorrow Casey | Senior IT Director | Leadership |
Jeffrey N. Simmons | President & CEO | Leadership |
Chris Keeley | SVP & Chief Information Officer | Leadership |
Erika Mendez | Sr Director Manufacturing Winslow, US | Leadership |
Fernanda Hoe | General Manager | Leadership |
Chad Cearns | Senior Director, Techops - Global Operations | Leadership |
Satya Sanampudi | Director - ERP Delivery And Operations | Leadership |
Kate Pangallo | Senior Director, Global Talent Development | Leadership |
John Fields | Sr Director Quality | Leadership |
Kristin Butler | Director Of Technical Services And Innovation | Launches - Canada | Leadership |
Vig J. | Director, Indirect Procurement APAC | Leadership |
Michael van Koevering | Senior Director Elanco Knowledge Solutions - Innovation And Sustainability | Leadership |
Bharat N. | Director HRIS -workday | Leadership |
Craig Hamilton | Director Of Quality Control | Leadership |
Bevan Skaalen | Director Of Antigen Production | Leadership |
Annie Hopper | Director - Process Automation Engineering | Leadership |
Jason Morgan | Director Environment Health Safety | Leadership |
Victor Guevara Fca | Chief Financial Officer, ANZ | Leadership |
Chad Michalski | Site Head | Senior Director, Manufacturing | Leadership |
Agata Ksionda | Senior Assistant General Counsel Ceertmea / Head Of Sanctions Compliance - EMEA & APAC | Leadership |
640 more people are available in the full profile.
Complete people profiles for KindredBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of KindredBio
5 dated milestones of KindredBio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded KindredBio is founded.
- Funding First funding round of $1.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $50.0M.
- Exit Acquired by Elanco.
Top companies in Veterinary Digital Health
3 companies that operate in the same segment as KindredBio (Veterinary Digital Health) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | |||
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | |||
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kindredbio
Complete news archive for KindredBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KindredBio
KindredBio was founded in 2012.
KindredBio is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.
KindredBio is a funded company, having raised a total of $6.9M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Nov 2012.
KindredBio has 64 employees.
Annual revenue of KindredBio is $42.16M as on Dec 31, 2020.
Kindred Biosciences was founded in 2012 and is headquartered in Burlingame, United States. Operations are centered on veterinary biotechnology, with a focus on antibody-based therapies for animal diseases. Treatments targeting conditions in cats, dogs, and horses have been developed by the company. Activities encompass research and development within the animal health sector, supporting therapeutic advancements for companion and equine species.
KindredBio has 2 investors. Key investors include Elanco, and SLR Investment Corp.
KindredBio operates through Kindred Biosciences, Inc..
Yes. KindredBio was acquired by Elanco in June 2021.